← Open Payments lookup

LAURA WELBORN: Open Payments

NPI 1265403661 · TOPEKA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,419 in 72 payments from 13 companies in 2025. Trend: 2023 $1,547 · 2024 $1,290 · 2025 $2,419

Food & beverage: $1,528Travel & lodging: $891
CompanyPaymentsAmount
Madrigal Pharmaceuticals12$1,342
ABBVIE INC.22$303
Takeda Pharmaceuticals U.S.A., Inc.8$161
Janssen Biotech, Inc.7$156
Salix Pharmaceuticals, a division of Bausch Health US, LLC7$148
Ipsen Biopharmaceuticals, Inc4$71
Regeneron Healthcare Solutions, Inc.3$63
Ardelyx, Inc.3$57
Intercept Pharmaceuticals, Inc.2$31
QOL Medical, LLC1$27

Products named: TREMFYA, XIFAXAN, SKYRIZI, ENTYVIO, REZDIFFRA, IQIRVO, DUPIXENT, RINVOQ.

Industry payments across KS — which companies pay providers there.